Table 2 Study population: patient characteristics
Total | Unrestricted Coverage | Restricted Coverage | |||
|---|---|---|---|---|---|
Characteristic | Lower-cost ICS User in 2003 | Higher-cost ICS User in 2003 | Lower-cost ICS User in 2003 | Higher-cost ICS User in 2003 | |
No. subjects | 1,802 | 293 | 175 | 847 | 487 |
Female* | 67.7% | 63.8% | 65.7% | 68.8% | 68.8% |
Age: 65–74 | 63.5% | 60.4% | 57.7% | 62.6% | 69.2% |
75–84 | 31.4% | 33.8% | 38.9% | 31.6% | 26.7% |
85+ | 5.1% | 5.8% | 3.4% | 5.8% | 4.1% |
Race/ethnicity*: White | 68.1% | 71.0% | 70.3% | 67.1% | 67.4% |
Black | 4.4% | 7.2% | 6.3% | 2.8% | 4.9% |
Hispanic | 6.9% | 3.1% | 2.9% | 8.5% | 8.0% |
Asian | 10.8% | 10.6% | 12.6% | 10.5% | 10.9% |
Other | 3.2% | 3.8% | 3.4% | 3.1% | 3.1% |
Unknown | 6.5% | 4.4% | 4.6% | 8.0% | 5.8% |
Neighborhood SES*: Non-low | 80.4% | 84.0% | 83.4% | 78.3% | 80.9% |
Low | 17.7% | 14.3% | 14.9% | 19.5% | 17.7% |
Unknown | 1.9% | 1.7% | 1.7% | 2.2% | 1.4% |
Coronary Artery Disease | 10.9% | 11.3% | 12.6% | 10.6% | 10.5% |
Diabetes | 15.5% | 14.0% | 15.4% | 15.9% | 15.6% |
Heart Failure* | 5.7% | 8.2% | 6.9% | 5.4% | 4.1% |
Hypertension | 55.9% | 61.8% | 55.4% | 56.9% | 50.7% |
Exceeded $1,000 drug cap in 2003 | -- | -- | -- | 21.3% | 44.2% |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |
Comorbidity (DxCG) score* | 0.94 (0.57) | 1.00 (0.65) | 1.02 (0.60) | 0.94 (0.57) | 0.89 (0.51) |